Advertisement

Zaleplon

  • B. GüssregenEmail author
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Hiemke C et al (2012) AGNP-Konsensus-Leitlinien für therapeutisches Drug-Monitoring in der Psychiatrie: Update 2011. Psychopharmakotherapie 19:91–122Google Scholar
  2. Nordgren H, Beck O (2004) Multicomponent screening for drugs of abuse. Direct analysis of urine by LC-MS-MS. Ther Drug Monit 26:90–97CrossRefGoogle Scholar
  3. Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Critical Care 16:R136CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Merck KGaADarmstadtDeutschland

Personalised recommendations